JPRN-UMIN000026793
Unknown
未知
Prospective observational study of biomarkers to predict efficacy after Pembrolizumab in patients with PD-L1 positive advanced non-small cell lung cancer. - Exploration of biomarker after Pembrolizumab in lung cancer
Conditionson-small cell lung cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- on-small cell lung cancer
- Sponsor
- Gunma University
- Enrollment
- 50
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Judgement as exclusion by chief mdical physians having auto\-immune diseases
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Prospective observational study of biomarkers to predict efficacy after Nivolumab in patients with previously treated advanced non-small cell lung cancer.on-small cell lung cancerJPRN-UMIN000020823Gunma University30
Completed
Not Applicable
A prospective observation study of biomarkers to predict patterns of recurrence after curative surgery for gastric cancerGastric cancerJPRN-UMIN000030111agoya University Graduate School of Medicine300
Completed
Not Applicable
A prospective observation study of biomarkers to detect or predict peritoneal metastasis of gastric cancerGastric cancerJPRN-UMIN000030112agoya University Graduate School of Medicine350
Not yet recruiting
Not Applicable
A prospective observational study of biomarkers for Second-line FOLFIRI plus Aflibercept treatment in patients with metastatic colorectal cancer comparing to FOLFIRI plus beVacizumab: an Exploratory biomarker study.colorectal cancerJPRN-UMIN000038508Kyoto University Hospital70
Completed
Not Applicable
Prospective research of the biomarkers associated with adjuvant chemotherapy in patients with resectable biliary tract cancerBiliary tract cancerJPRN-UMIN000004613Department of Medical Oncology, University of Miyazaki Hospital50